Start › Rak płaskonabłonkowy głowy i szyi › Teksas › Houston
Badania kliniczne dla Rak płaskonabłonkowy głowy i szyi w mieście Houston, TX
47 badań dla Rak płaskonabłonkowy głowy i szyi szuka uczestników w ośrodkach w mieście Houston i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RekrutacjaFaza 1
- University of Texas MD Anderson Cancer Center, Houston
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
RekrutacjaFaza 2/3
- Site#0102, Houston
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
RekrutacjaFaza 1/2
- MD Anderson Cancer Center, Houston
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RekrutacjaFaza 1
- University of Texas MD Anderson Cancer Center, Houston
- The University of Texas, MD Anderson Cancer Center - West Houston, Houston
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
RekrutacjaFaza 1
- ALX Center 5, Houston
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
RekrutacjaFaza 1
- Research Site, Houston
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
RekrutacjaFaza 3
- MD Anderson Cancer Center, Houston
Intratumoral N17350 in Advanced Solid Tumors
RekrutacjaFaza 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RekrutacjaFaza 1
- Oncology Consultants, P.A., Houston
- University of Texas M.D. Anderson Cancer Center, Houston
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
RekrutacjaFaza 1/2
- MD Anderson Cancer Center, Houston
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RekrutacjaFaza 1/2
- MD Anderson Cancer Center, Houston
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
RekrutacjaFaza 1
- MD Anderson Cancer Center, Houston
ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours
RekrutacjaFaza 1
- MD Anderson Cancer Center, Houston
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
RekrutacjaFaza 1
- M. D. Anderson Cancer Center, Houston
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1/2
- Research Site, Houston
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
RekrutacjaFaza 1
- Normunity Investigational Site, Houston
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
RekrutacjaFaza 2/3
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
- Michael E DeBakey VA Medical Center, Houston
- UT MD Anderson Cancer Center, Houston
- i 1 więcej
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
RekrutacjaFaza 1/2
- Houston Methodist Hospital, Houston
SMP-3124LP in Adults With Advanced Solid Tumors
RekrutacjaFaza 1/2
- MD Anderson Cancer Center, Houston
A Study of MGC026 in Participants With Advanced Solid Tumors
RekrutacjaFaza 1
- The University of Texas MD Anderson Cancer Center, Houston
- University of Texas Health Science Center at Houston, Houston
3-5 FrAction Stereotactic Body Radiation Therapy for Palliation of Head and Neck Squamous Cell Carcinoma: the FAST Phase II Randomized Trial
RekrutacjaFaza 2
- M D Anderson Cancer Center, Houston
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
RekrutacjaFaza 1/2
- Oncology Consultants, Houston
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RekrutacjaFaza 1
- The University of Texas MD Anderson Cancer Center Investigational Pharmacy Services, Houston
- The University of Texas MD Anderson Cancer Center, Houston
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RekrutacjaFaza 1/2
- University of Texas MD Anderson Cancer Center, Houston
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RekrutacjaFaza 1
- Oncology Consultants, PA, Houston
- Oncology Consultants, PA., Houston
- The University of Texas M.D. Anderson Cancer Center, Houston
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
RekrutacjaFaza 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
RekrutacjaFaza 1
- The University of Texas MD Anderson Cancer Center /ID# 270059, Houston
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
RekrutacjaFaza 1
- MD Anderson, Houston
- NEXT Texas LLC - Houston, Houston
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
RekrutacjaFaza 1
- MD Anderson Cancer Center, Houston
Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A "Window of Opportunity" Pilot Study.
RekrutacjaFaza 4
- MD Anderson Cancer Center, Houston
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
RekrutacjaFaza 1
- University of Texas MD Anderson Cancer Center /ID# 252004, Houston
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
RekrutacjaFaza 1
- M D Anderson Cancer Center, Houston
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
RekrutacjaFaza 2
- USA12-0, Houston
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
RekrutacjaFaza 1
- MD Anderson Cancer Center, Houston
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
RekrutacjaFaza 3
- MD Anderson Cancer Center, Houston
- Oncology Consultants, Houston
A Study of VET3-TGI in Patients With Solid Tumors
RekrutacjaFaza 1
- University of Texas MD Anderson Cancer Center, Houston
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RekrutacjaFaza 1
- MD Anderson Cancer Center, Houston
Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
RekrutacjaFaza 1
- Baylor St. Luke's Medical Center, Houston
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RekrutacjaFaza 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
Rekrutacja
- Baylor College of Medicine, Houston
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RekrutacjaFaza 1/2
- The University of Texas MD Anderson Cancer Center (site 127), Houston
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
RekrutacjaFaza 1/2
- M.D. Anderson Cancer Center, Houston
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
RekrutacjaFaza 3
- University of Texas, MD Anderson Cancer Center, Houston
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
RekrutacjaFaza 1/2
- MD Anderson Cancer Center, Houston
A Study of NX-1607 in Adults With Advanced Malignancies
RekrutacjaFaza 1
- MD Anderson Cancer Center, Houston
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
RekrutacjaFaza 1
- MD Anderson Cancer Center, Houston
A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab
RekrutacjaFaza 1/2
- MD Anderson Cancer Center, Houston
Badania dla Rak płaskonabłonkowy głowy i szyi w innych miastach
- Los Angeles, CA42 badań
- Boston, MA40 badań
- New York City, NY39 badań
- Nashville, TN39 badań
- St. Louis, MO28 badań
- Arlington, VA26 badań
- Philadelphia, PA26 badań
- Chicago, IL26 badań
- Atlanta, GA24 badań
- San Antonio, TX22 badań
- New Haven, CT22 badań
- Pittsburgh, PA22 badań
Inne badania w mieście Houston
- Niedrobnokomórkowy rak płuca145 badań
- Rak piersi126 badań
- Nowotwory (wszystkie typy)121 badań
- Nowotwór przerzutowy104 badań
- Rak jelita grubego i odbytnicy102 badań
- Rak jajnika89 badań
- Ostra białaczka szpikowa85 badań
- Rak płuc78 badań
- Rak prostaty76 badań
- Rak endometrium68 badań
- Rak trzustki61 badań
- Czerniak59 badań
Źródło: ClinicalTrials.gov, dane pobrane 6 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.